Journal of Neuro-Oncology

, Volume 16, Issue 2, pp 167–172 | Cite as

Postoperative hypofractionated radiotherapy versus conventionally fractionated radiotherapy in malignant gliomas. A preliminary report on a randomized trial

  • Bogdan Glinski
Clinical Study

Abstract

A prospective randomized study of 108 patients with cerebral malignant gliomas was carried out at the Department of Radiation Oncology of Maria Sklodowska-Curie Memorial Center in Kraków. 44 patients with histologically proven glioblastoma multiforme and 64 patients with anaplastic astrocytoma received postoperative radiotherapy. Patients were randomized to two treatment arms: Conventionally Fractionated Radiotherapy (CFR) and Hypofractionated Radiotherapy (HF). In the CFR group, the whole brain was irradiated to the total dose of 50 Gy in 25 fractions over 5 weeks, then a 10 Gy ‘boost’ in 5 fractions in 5 days was delivered to the site of the primary lesion. In the HF group, there were 3 courses of irradiation separated by a one month interval. In each of the two first series the patients received 20 Gy in 5 fractions in 5 days to the whole brain, and in the third course, 10 Gy ‘boost’ in 5 days was delivered as in the CFR regimen. The tolerance to treatment has been found to be good in both groups. The 2-year actuarial survival rate for patients with anaplastic astrocytoma was 22% for CFR and 18% for HF. Patients with glioblastoma multiforme treated with HF had a better prognosis in comparison to the CFR group with the two-year actuarial survival rates being 23% and 10%, respectively. This difference is statistically significant at the 0.05 level.

Key words

malignant glioma radiotherapy hypofractionation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jose B, Duncan A, Paris K, Lindsay RD, Spares WJ: Glioblastoma multiforme in adults. Results of treatment. J Can Med Assoc 88: 650–652, 1990Google Scholar
  2. 2.
    Gliński B, Reinfuss M: Radiothérapie post-operatoire des glioblastomes. J Eur Radiothér 7: 15–18, 1986Google Scholar
  3. 3.
    Kallio M: Therapy and survival of adult patients with intracranial glioma in defined population. Acta Neurol Scan 81: 541–549, 1990Google Scholar
  4. 4.
    Shibamoto Y, Yamashita J, Takahashi M, Yamasaki M, Abe M: Supratentorial malignant glioma: An analysis of radiation therapy in 178 cases. Radiotherapy and Oncology 18: 9–17, 1990Google Scholar
  5. 5.
    Andersen AP: Postoperative irradiation of glioblastoma. Results in a randomized series. Acta Radiol Oncol 17: 475–484, 1978Google Scholar
  6. 6.
    Garcia DN, Fulling KH, Marks JE: The value of radiation therapy in addition to surgery for astrocytoma of the adult cerebrum. Cancer 55: 919–927, 1985Google Scholar
  7. 7.
    Walker MD, Alexander E, Hunt W, Mahaley MS, Mealey J, Norell H, Owens G, Ranschoff J, Wilson CB, Gehan EA, Strike TA: Evaluation of BCNU and/or radiotherapy of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49: 333–343, 1978Google Scholar
  8. 8.
    Zulch KJ: Histological Classification of Tumors of the Central Nervous System. WHO (ed), Geneva, 1979, pp 29–30Google Scholar
  9. 9.
    Karnofsky DA, Burchenal JM: The clinical evaluation of chemotherapeutic agents in cancer. In: MacLead (ed) Evaluation of Chemotherapeutic Agents. Columbia Univ Press, New York, 1949, pp 191–205Google Scholar
  10. 10.
    Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481, 1958Google Scholar
  11. 11.
    Gehan EA: A generalized Wilcoxon test for comparing arbitrarily singly censored samples. Biometrika 52: 203–223, 1965Google Scholar
  12. 12.
    Kramer S: Brain tumors. Editorial. Where have we been? Where are we going? Sem Oncol 2: 3–4, 1975Google Scholar
  13. 13.
    Hercbergs A, Tadmor R, Findler G, Sahar A, Brenner H: Hypofractionated radiation therapy and concurrent cisplatin in malignant cerebral gliomas. Rapid palliation in low performance status patients. Cancer 64: 816–820, 1989Google Scholar
  14. 14.
    Kapp DS, Wagner FC, Lawrence R: Glioblastoma multiforme. Treatment by large dose fraction irradiation and metronidazol. Int J Radiat Oncol Biol Phys 8: 351–355, 1983Google Scholar
  15. 15.
    Le Bourgeois JP, Schlienger M, Constans JP, Askienazy S: Irradiation concentrée des glioblastomes. Bulletin du Cancer 64: 145–150, 1977Google Scholar
  16. 16.
    Marcial-Vega VA, Wharam MD, Leibel S, Clark A, Zweig R, Order E: Treatment of supratentorial high grade gliomas with split course high fractional dose postoperative radiotherapy. Int J Radiat Oncol Biol Phys 16: 1419–1424, 1989Google Scholar
  17. 17.
    Sautter-Bihl MI, Barcsay E, Liebermeister E, Winheller P, Liesegang J, Heinze HG: Radiotherapy of glioblastomas. Is shortening of the treatment justifiable. Strahlenther Oncol 167: 7–13, 1991Google Scholar
  18. 18.
    Schlienger M, Constans JP, Roujeau J, Askienazy S: Resultats de l'irradiation concentrée dans les glioblastomes, astrocytomes malins et les métastases cérébrales de l'adulte. J Radiol Electrol Med Nucl 57: 831–834, 1976Google Scholar
  19. 19.
    Tamura M, Nakamura M, Kumimine K, Ono N, Niiba H, Hayakawa: Large dose fraction radiotherapy in the treatment of glioblastoma. J Neurooncol 7: 113–119, 1989Google Scholar

Copyright information

© Kluwer Academic Publishers 1993

Authors and Affiliations

  • Bogdan Glinski
    • 1
  1. 1.Department of Radiation Oncology of Maria Sklodowska-Curie Memorial CenterKrakowPoland

Personalised recommendations